NCT02703649View on ClinicalTrials.gov

Administration of Single High Dose Letrozole for Ovulation Induction

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Anovulation
Interventions
DRUG

Letrozole

After the decision to use Letrozole for induction of ovulation, we will obtain informed consent and randomize the patents into 2 groups Single 20 mg dose of Letrozole on day 3 of the cycle Daily dose of Letrozole 2.5 mg starting day 3 for 5 days.

Trial Locations (2)

M5G 1X5

Mount Sinai Hospital, University of Toronto, Toronto

M5G 2K4

TRIO Fertility, Toronto

All Listed Sponsors
lead

Mount Sinai Hospital, Canada

OTHER

NCT02703649 - Administration of Single High Dose Letrozole for Ovulation Induction | Biotech Hunter | Biotech Hunter